LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to its board.
Jan Groen joins the board of Angle with immediate effect as a non-executive director. His is currently president and chief executive at MDxHealth, which develops and commercialises tests to detect urological and other cancers.
Before his role at MDxHealth Inc, Groen was president of US operations and global chief operating officer of cancer diagnostics company Agendia Inc, which developed a test to predict breast cancer recurrence based on the gene expression of tumours.
In addition, Groen is also holds a non-executive board position at private Dutch company SPL Medical BV. He was previously a board member at Belgian company MyCartis NV.
Shares in Angle were up 0.6% at 41.50 pence on Thursday.
Angle (AGL)